相关实验视频

Updated: Jul 19, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

塑造SCLC的瘤免疫微环境:免疫治疗的机制和机会

Yunfei Chen¹, Hui Li¹, Yun Fan¹

¹Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China; Postgraduate Training base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, Zhejiang 310022, China.

Cancer treatment reviews

|August 14, 2023

概括

小细胞肺癌 (SCLC) 免疫疗法显示出希望,但其瘤免疫微环境 (TIME) 提出了挑战. 了解SCLC 的理解

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
基因组学就是基因组学.

背景情况:

小细胞肺癌 (SCLC) 是一种具有不良预后的侵袭性神经内分泌瘤.
免疫疗法为SCLC治疗提供了潜力,但患者的反应通常受到瘤免疫微环境 (TIME) 的限制.

研究的目的:

为了全面描述SCLC的时间.
为了阐明驱动SCLC TIME形成的机制.
确定改善SCLC免疫疗法疗效的策略.

主要方法:

审查与SCLC相关的多omics数据 (基因组学,表观基因组学,代谢学).
分析瘤生物学与SCLC中的TIME之间的相互作用.
对SCLC TIME特征和监管机制的当前知识的综合.

主要成果:

SCLC表现出一种独特的 TIME,它影响免疫疗法反应.
基因组,表观基因组和代谢组因素显著影响了SCLC的时间.
多omics方法为SCLC的TIME调节提供了深入的见解.

结论:

描述SCLC的时间对于促进免疫疗法的发展至关重要.
准时间调节机制为未来的治疗机会提供了机会.
需要进一步的研究来克服SCLC的免疫治疗挑战.

关键词:

免疫治疗是一种免疫疗法.小细胞肺癌是一种小细胞肺癌.瘤的免疫微环境

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...